down arrow

Global Health

  • Market Cap: Large Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE474Q01031
  • NSEID: MEDANTA
  • BSEID: 543654
INR
1,277.00
48.3 (3.93%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.51 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,226.001,277.00

52 Week

936.051,510.10
Valuation
Technical
Day's Volume

CASH

1.51 lacs (25.05%) Volume

Shareholding (Dec 2024)

FII

12.47%

Held by 147 FIIs

DII

10.51%

Held by 25 DIIs

Promoter

33.03%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

High Management Efficiency with a high ROE of 15.54%

 
2

Company has a low Debt to Equity ratio (avg) at 0 times

 
3

Healthy long term growth as Operating profit has grown by an annual rate 29.54%

 
4

Positive results in Dec 24

5

Stock is technically in a Bullish range

6

High Institutional Holdings at 22.98%

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 34,299 Cr (Large Cap)

stock-summary
P/E

65.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.09

stock-summary
Return on Equity

15.54%

stock-summary
Price to Book

10.51

Revenue and Profits (1 Year):
Net Sales:
943 Cr
(Quarterly Results - Dec 2024)
Net Profit:
143 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
24.49%
0%
24.49%
1 Year
-10.38%
0%
-10.38%
2 Years
164.09%
0%
164.09%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Global Health for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.21%
EBIT Growth (5y)
29.54%
EBIT to Interest (avg)
7.30
Debt to EBITDA (avg)
1.20
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.86
Tax Ratio
22.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
22.98%
ROCE (avg)
22.43%
ROE (avg)
15.54%
Valuation key factors
Factor
Value
P/E Ratio
65
Industry P/E
55
Price to Book Value
10.51
EV to EBIT
50.96
EV to EBITDA
39.32
EV to Capital Employed
11.49
EV to Sales
9.16
PEG Ratio
5.32
Dividend Yield
NA
ROCE (Latest)
21.93%
ROE (Latest)
15.54%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 24 Schemes (9.0%)

FIIs

Held by 147 FIIs (12.47%)

Promoter with highest holding

Naresh Trehan (33.03%)

Highest Public shareholder

Dunearn Investments (mauritius) Pte Ltd (14.86%)

Individual Investors Holdings

6.74%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -1.37% vs 11.09% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 9.23% vs 23.10% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "943.44",
          "val2": "956.56",
          "chgp": "-1.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "237.77",
          "val2": "228.29",
          "chgp": "4.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "16.28",
          "val2": "15.98",
          "chgp": "1.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "142.91",
          "val2": "130.84",
          "chgp": "9.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "25.20%",
          "val2": "23.87%",
          "chgp": "1.33%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 12.41% vs 24.72% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 4.38% vs 57.33% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,817.63",
          "val2": "1,616.98",
          "chgp": "12.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "414.61",
          "val2": "390.73",
          "chgp": "6.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "33.95",
          "val2": "38.00",
          "chgp": "-10.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "237.13",
          "val2": "227.17",
          "chgp": "4.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.81%",
          "val2": "24.16%",
          "chgp": "-1.35%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 12.54% vs 23.24% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.33% vs 55.92% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,761.07",
          "val2": "2,453.43",
          "chgp": "12.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "652.38",
          "val2": "606.67",
          "chgp": "7.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "50.23",
          "val2": "55.68",
          "chgp": "-9.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "380.04",
          "val2": "350.81",
          "chgp": "8.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.63%",
          "val2": "24.73%",
          "chgp": "-1.10%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 20.86% vs 25.03% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 46.65% vs 66.20% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,275.11",
          "val2": "2,709.88",
          "chgp": "20.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "799.08",
          "val2": "627.84",
          "chgp": "27.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "73.91",
          "val2": "77.92",
          "chgp": "-5.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "478.19",
          "val2": "326.08",
          "chgp": "46.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.40%",
          "val2": "23.17%",
          "chgp": "1.23%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
943.44
956.56
-1.37%
Operating Profit (PBDIT) excl Other Income
237.77
228.29
4.15%
Interest
16.28
15.98
1.88%
Exceptional Items
0.00
0.00
Consolidate Net Profit
142.91
130.84
9.23%
Operating Profit Margin (Excl OI)
25.20%
23.87%
1.33%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -1.37% vs 11.09% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 9.23% vs 23.10% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,817.63
1,616.98
12.41%
Operating Profit (PBDIT) excl Other Income
414.61
390.73
6.11%
Interest
33.95
38.00
-10.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
237.13
227.17
4.38%
Operating Profit Margin (Excl OI)
22.81%
24.16%
-1.35%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 12.41% vs 24.72% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 4.38% vs 57.33% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,761.07
2,453.43
12.54%
Operating Profit (PBDIT) excl Other Income
652.38
606.67
7.53%
Interest
50.23
55.68
-9.79%
Exceptional Items
0.00
0.00
Consolidate Net Profit
380.04
350.81
8.33%
Operating Profit Margin (Excl OI)
23.63%
24.73%
-1.10%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 12.54% vs 23.24% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 8.33% vs 55.92% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
3,275.11
2,709.88
20.86%
Operating Profit (PBDIT) excl Other Income
799.08
627.84
27.27%
Interest
73.91
77.92
-5.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
478.19
326.08
46.65%
Operating Profit Margin (Excl OI)
24.40%
23.17%
1.23%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 20.86% vs 25.03% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 46.65% vs 66.20% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Global Health Ltd stock-summary
stock-summary
Global Health Ltd
Large Cap
Hospital & Healthcare Services
Global Health Limited (GHL) was incorporated as `Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Limited Company. The Company converted into a Public Limited Company and name of the Company was changed to `Global Health Limited' dated August 11, 2021 issued by the RoC. Presently, the Company is engaged in the business of providing healthcare services. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."